[Incorporation monitoring of employees of a radioiodine therapy ward. Is incorporation monitoring required for routine?].
Aim of the study was to determine the annual incorporation of staff on a radioiodine therapy ward and the resulting annual effective dose (aed). Following the German incorporation guideline (gig), incorporation monitoring is not necessary for potential aed below 0.5 mSv/a. For aed > 0.5 mSv/a adherence to the 1 mSv dose limit must be verified. For doses > 1 mSv/a incorporation has to be monitored by the authority. Furthermore, the (131)I incorporation factor from the gig should be verified.


METHODS
To determine the actual work related incorporation, the (131)I activity concentration in urine samples (collection over 24 h) of 14 employees of different professions were examined over a period of 27 months.


RESULTS
Measured activity concentrations were related to the individual time of exposure. A constant activity supply for at least three days was assumed. The mean annual effective doses were 2.4 · 10⁻¹ mSv/a (nursing staff; n = 3), 5.6 · 10⁻² mSv/a (cleaning staff; n = 2), 2.8 · 10⁻³ mSv/a (technical staff; n = 2) and 5.2 · 10⁻³ mSv/a (physicians; n = 7). All aed were below the dose limits of the gig. The calculated mean incorporation factors ranged from 3.0 · 10⁻⁸ for the nursing staff to 3.6 · 10⁻¹⁰ for the technical staff (cleaning staff: 7 · 10⁻⁹; physicians: 6.5 · 10⁻¹⁰) and were therefore well below the (131)I incorporation factor defined by the gig.


CONCLUSIONS
To estimate the aed caused by incorporation of (131)I it has to be subdivided for the different requirements in the diverse fields of activity of the employees. Regarding those who spend most of their time nearby the patient an incorporation monitoring by the authority might be required. The (131)I incorporation factor from the guideline (10⁻⁶) can be reduced by a factor of 10. For (99m)Tc and (18)F an incorporation factor of 10⁻⁷ is accepted.
Klinikum der Johann Wolfgang Goethe Universität, Klinik für Nuklearmedizin, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany. Christian.Happel@kgu.de
C
C
Happel
U
U
Kratzel
I
I
Selkinski
B
B
Bockisch
M
M
Etzel
H
H
Korkusuz
B
B
Sauter
J
J
Staudt
F
F
von Müller
F
F
Grünwald
W T
WT
Kranert
D006801:Humans; D007457:Iodine Radioisotopes / Q000032:analysis* / Q000627:therapeutic use*; D016273:Occupational Exposure / Q000032:analysis* / Q000517:prevention & control*; D011829:Radiation Dosage; D011834:Radiation Monitoring / Q000379:methods*; D011835:Radiation Protection / Q000379:methods*; D017751:Safety Management / Q000379:methods / Q000458:organization & administration
D007457:Iodine Radioisotopes